factual

FDA Amplified Rare Edge Cases to Yank Vaccine

The FDA is not optimized for correct tradeoffs between type-one and type-two errors, as shown when it amplified very rare thrombosis edge cases to yank the Johnson & Johnson vaccine despite large-scale benefit, and when in February 2020 it made it very hard to run diagnostics on the novel coronavirus until the Seattle Flu Study committed civil disobedience.

factualpending

Speaker

Balaji Srinivasan

Evidence Quote

“they're not optimized for making the correct trade-off between type one and type two errors”

Source

259 - The Reckoning To Come— Making Sense with Sam Harris
Created: 6/14/2026, 2:23:35 AM

Your notes

Loading notes...